WealthSource Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.86M Sell
17,055
-121
-0.7% -$12.6K 0.12% 130
2023
Q3
$1.77M Sell
17,176
-257
-1% -$27.7K 0.12% 137
2023
Q2
$2.01M Sell
17,433
-3,264
-16% -$371K 0.13% 120
2023
Q1
$2.2M Sell
20,697
-2,637
-11% -$285K 0.15% 109
2022
Q4
$2.59M Sell
23,334
-5,444
-19% -$556K 0.18% 90
2022
Q3
$2.48M Sell
28,778
-3,118
-10% -$278K 0.18% 93
2022
Q2
$2.91M Sell
31,896
-57,896
-64% -$5.13M 0.21% 80
2022
Q1
$7.37M Buy
89,792
+70,398
+363% +$5.55M 0.5% 35
2021
Q4
$1.49M Buy
19,394
+1,951
+11% +$155K 0.12% 138
2021
Q3
$1.31M Buy
17,443
+550
+3% +$41.8K 0.11% 139
2021
Q2
$1.31M Sell
16,893
-1,260
-7% -$93.7K 0.12% 133
2021
Q1
$1.33M Buy
18,153
+1,136
+7% +$83.8K 0.13% 121
2020
Q4
$1.33M Buy
17,017
+1,558
+10% +$119K 0.15% 91
2020
Q3
$1.22M Buy
15,459
+4,006
+35% +$314K 0.16% 87
2020
Q2
$845K Sell
11,453
-5,066
-31% -$381K 0.12% 114
2020
Q1
$1.21M Sell
16,519
-2,568
-13% -$202K 0.19% 74
2019
Q4
$1.66M Sell
19,087
-262
-1% -$21.5K 0.22% 86
2019
Q3
$1.55M Buy
19,349
+1,731
+10% +$139K 0.23% 98
2019
Q2
$1.41M Buy
17,618
+6,993
+66% +$535K 0.22% 107
2019
Q1
$843K Buy
10,625
+2,556
+32% +$191K 0.19% 113
2018
Q4
$588K Buy
8,069
+54
+0.7% +$3.81K 0.17% 130
2018
Q3
$543K Buy
8,015
+2,205
+38% +$140K 0.14% 145
2018
Q2
$337K Sell
5,810
-1,917
-25% -$108K 0.09% 197
2018
Q1
$402K Sell
7,727
-3,475
-31% -$188K 0.12% 170
2017
Q4
$601K Buy
11,202
+61
+0.5% +$3.38K 0.19% 119
2017
Q3
$681K Sell
11,141
-1,401
-11% -$84.9K 0.23% 103
2017
Q2
$767K Sell
12,542
-752
-6% -$45.8K 0.26% 93
2017
Q1
$806K Buy
13,294
+887
+7% +$53.8K 0.3% 86
2016
Q4
$697K Sell
12,407
-455
-4% -$26.6K 0.29% 74
2016
Q3
$766K Buy
12,862
+8,345
+185% +$488K 0.28% 79
2016
Q2
$248K Buy
4,517
+175
+4% +$9.31K 0.09% 201
2016
Q1
$219K Buy
+4,342
New +$213K 0.09% 201

Other funds holding MRK

WealthSource Partners's MRK Position: Q4 2023 in Review

WealthSource Partners reduced its Merck (MRK) stake by 0.7% in Q4 2023, selling an estimated $12.6K and leaving 17,055 shares worth $1.86M. The position accounts for 0.12% of the portfolio, ranked #130.

WealthSource Partners first reported a position in MRK in Q1 2016 and has held it in 32 quarters since. The position peaked at $7.37M in Q1 2022. 3,435 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • WealthSource Partners held 17,055 shares of Merck worth $1.86M as of Q4 2023.
  • WealthSource Partners sold 121 Merck shares in Q4 2023, an estimated $12.6K.
  • Merck made up 0.12% of WealthSource Partners's portfolio in Q4 2023, its #130 holding.
  • WealthSource Partners first reported a position in Merck in Q1 2016 and has held it in 32 quarters since.
  • WealthSource Partners's Merck position peaked at $7.37M in Q1 2022.
  • 3,435 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on WealthSource Partners's 13F filing for Q4 2023, filed 16 Jan 2024.